StocksMedium•4 November 2026•
1 min read
GSK India Q2 Profit Jumps 30% to ₹335.88 Crore on Strong Sales
Key Facts
1GSK India reported a 30.44% increase in consolidated net profit to ₹335.88 crore for the quarter ended September.
2Total income rose to ₹1,256.35 crore during the second quarter, up from ₹1,013.51 crore a year earlier.
GSK India reported a 30.44% increase in consolidated net profit to ₹335.88 crore for the quarter ended September. HDFC Sky reported that the company's total income rose to ₹1,256.35 crore during the second quarter, up from ₹1,013.51 crore a year earlier.
The growth was attributed to strong sales performance across the company's general medicines, vaccines, and specialty medicines portfolios. In equity markets, GSK closed at $48.7 on November 3, 2026, with a session high of $49.57 and a low of $48.62.